Collagen supplement may turn back the clock on aging cells
NCT ID NCT07456449
First seen Mar 11, 2026 · Last updated Jun 23, 2026 · Updated 17 times
Summary
This study tests whether taking collagen peptides daily for 6 months can help slow aging at the cellular level in adults aged 50-70 who are overweight and not very active. Researchers will measure telomere length (a marker of cellular age), inflammation, and body composition. 125 participants will be randomly assigned to take either collagen or a placebo, with blood tests and physical assessments at the start, 3 months, and 6 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY AGING are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Vienna, NuTraLab
RECRUITINGVienna, State of Vienna, 1070, Austria
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
collagen peptides
What this could lead to
If it works, this could point toward a simple dietary supplement that supports healthier aging at the cellular level.
What could go wrong
This is an early-stage, small study (125 people) testing a supplement, not a drug. Results may show no effect on telomeres or aging markers, and any benefits may not apply to the general population.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.